(RTTNews) - Hims & Hers Health, Inc. (HIMS), a health and wellness platform, on Monday announced that its board has authorized a new share repurchase program of up to $250 million in Class A common stock over the next three years
The repurchase follows the full utilization of its prior $100 million program launched in July 2024.
The company said the decision reflects its view that the current market value of its stock may not fully represent its intrinsic value.
In the pre-market trading, Hims & Hers Health is 0.11% higher at $36.98 on the New York Stock Exchange.
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
